Recombinant human truncated Tau seeds as well as FTD brain-derived Tau aggregates were demonstrated to be potent NLRP3 inflammasome activators in cultured microglia and in transgenic mutant-Tau overexpressing mice (60, 61). This evidence concerns the gene MAPT and frontotemporal dementia.